UNSPSC 51284118: Ceftioxide

This classification denotes a cephalosporin antibiotic with the molecular formula C16H17N5O8S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6Z9DV0V6TG, chemically known as (5s,6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-2-ene-carboxylic acid 7,2-(z)-(o-methyloxime), acetate (ester), 5-oxide but generally known as ceftioxide, which bears US NIH Compound Identifier 9589416.

UNSPSC 51284118 Ceftioxide is a Commodity code that in recent state and local solicitations actually maps to a broader pharmaceutical procurement activity — generic multi-source pharmaceuticals, over-the-counter products, medical supplies, and specialty medications such as naloxone — rather than ceftioxide specifically. State and local buyers under this code include county health departments, state health and human services agencies, municipal fire and rescue services, and cooperative purchasing alliances that aggregate demand across multiple jurisdictions. The work being solicited ranges from standing contracts for emergency medical supplies (cardiac monitoring devices, airway equipment, bandaging materials) with quarterly or on-demand delivery, to statewide pharmaceutical distribution agreements through authorized wholesalers, to direct-to-manufacturer prescription initiatives managed by health benefit programs. Issuing bodies span state health agencies, county governments, city purchasing departments, and multi-state cooperative purchasing vehicles.

Recent opportunities show activity across Florida, Texas, and Minnesota. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) posted an RFP on January 20, 2026 for generic multi-source pharmaceuticals and OTC products with proposals due March 26, 2026, requiring vendors to supply through authorized wholesalers and comply with cGMP and Drug Supply Chain Security Act certification. The City of Tampa issued an IFB on March 25, 2026 for medical and first aid supplies totaling an estimated $700,000.00 with a March 13, 2026 response date, designated as a sheltered-market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a July 26, 2023 response date. The Texas Health and Human Services Commission issued an RFI on April 3, 2026 to gather vendor capabilities on direct-to-manufacturer prescription programs for self-insured state health plans, operating as exploratory market intelligence ahead of formal procurement.